Literature DB >> 22654658

cAMP and EPAC are key players in the regulation of the signal transduction pathway involved in the α-hemolysin autophagic response.

María Belén Mestre1, María Isabel Colombo.   

Abstract

Staphylococcus aureus is a microorganism that causes serious diseases in the human being. This microorganism is able to escape the phagolysosomal pathway, increasing intracellular bacterial survival and killing the eukaryotic host cell to spread the infection. One of the key features of S. aureus infection is the production of a series of virulence factors, including secreted enzymes and toxins. We have shown that the pore-forming toxin α-hemolysin (Hla) is the S. aureus-secreted factor responsible for the activation of the autophagic pathway and that this response occurs through a PI3K/Beclin1-independent form. In the present report we demonstrate that cAMP has a key role in the regulation of this autophagic response. Our results indicate that cAMP is able to inhibit the autophagy induced by Hla and that PKA, the classical cAMP effector, does not participate in this regulation. We present evidence that EPAC and Rap2b, through calpain activation, are the proteins involved in the regulation of Hla-induced autophagy. Similar results were obtained in cells infected with different S. aureus strains. Interestingly, in this report we show, for the first time to our knowledge, that both EPAC and Rap2b are recruited to the S. aureus-containing phagosome. We believe that our findings have important implications in understanding innate immune processes involved in intracellular pathogen invasion of the host cell.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22654658      PMCID: PMC3359991          DOI: 10.1371/journal.ppat.1002664

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


Introduction

Autophagy is a cellular process in response to stress, which is activated when cells are subjected to nutrient limitation, high temperatures, oxidative stress, accumulation of damaged organelles, or infection with certain pathogens [1]. When autophagy is activated, various cellular constituents, including long-lived proteins, cytoplasmic organelles, and some microorganisms, are encapsulated by the phagophore, a growing cistern that finally closes generating the autophagosome lined by two membranes. These vesicles intersect with the endosomal compartment, generating the amphisome, which finally fuses with lysosomes to become autolysosomes, where sequestered cellular components are digested and essential molecules are recycled back to the cytoplasm [2]. Genetic studies in yeast have led to the discovery of several Atg (autophagy related) genes, many of which have mammalian orthologs [3]. Atg12-Atg5 and the Atg8 systems are key components of the autophagic pathway. Atg5 interacts covalently with Atg12 and noncovalently with the multimeric protein Atg16. The microtubule-associated protein 1 light chain 3 (MAP1-LC3/Atg8/LC3) is cleaved at its C terminus by Atg4 to form LC3-I, which is covalently conjugated to phosphatidylethanolamine to generate LC3-II. LC3-II is formed where the Atg12-Atg5-Atg16 complex is localized and it remains associated with autophagosomes, even with mature autophagosomes/autolysosomes although at a lesser degree [4], [5]. Two main mechanisms involved in the regulation of the classical autophagy pathway have been described. One of them involves the serine/threonine kinase, mammalian target of rapamycin (mTOR), which inhibits autophagy and functions as a sensor for cellular energy and amino acid levels [3], [6]. The other one is through phosphatidylinositol-3-kinase (PI3K) Class III, which plays an important role in the activation of the autophagic pathway, acting as a positive regulator. Class III PI3K and its human ortholog hVps34 interact with Beclin 1 and p150 myristoylated kinase, activating some of the Atg proteins involved in the autophagic pathway [7]. More recently, a new kind of autophagic pathway independent of mTOR and rapamycin has been revealed [8]. Rubinsztein and coworkers demonstrated that autophagy can be induced by lowering intracellular inositol or inositol 1,4,5-trisphosphate (IP3) levels, in a mTOR-independent form [8], [9]. Consistently, Kroemer and collaborators have shown that genetic knockdown or pharmacological inhibition of the IP3 receptor (IP3R) induces autophagy [10]. Interestingly, it has been recently shown that IP3R represses autophagy through Bcl-2-mediated sequestration of Beclin 1 [11], thus linking IP3R with initial steps of the autophagic pathway. Cumulative evidence indicates that autophagy is involved in the defense against several pathogen microorganisms [1], [12], [13]. Upon autophagy induction, intracellular bacteria such as Streptococcus pyogenes, Mycobacterium tuberculosis, and Salmonella are sequestrated within autophagosomes which then fuse with lysosomes to eliminate the intruder [13]. However, some pathogens like Coxiella burnetti and Legionella pneumophila benefit from autophagy and generate a replicative niche with autophagic features where the bacteria can actively replicate [12]. Other bacteria like Shigella flexneri and Listeria monocytogenes can escape from the phagosomes into the cytoplasm, where they multiply and generate actin tails to disseminate from the host cell to neighboring cells [12]. Staphylococcus aureus is a microorganism that causes serious diseases in humans. S. aureus has been classically considered an extracellular pathogen, but numerous studies have now shown that S. aureus can infect various types of non-professional phagocytic cells such as keratinocytes, fibroblasts, endothelial, and epithelial cells, leading to host cell death [14]–[17] S. aureus is able to escape the phagolysosomal pathway and, in this way, increase the intracellular bacterial survival and killing of the eukaryotic host cell, spreading the infection [18]. A previous study has shown that after the infection, S. aureus localizes to autophagosomes and inhibits its maturation and fusion with lysosomes [18]. Interestingly, S. aureus was not able to replicate in autophagy-deficient Atg5−/− mouse embryonic fibroblasts, indicating that S. aureus requires autophagy activation for replication, subsequent escape from autophagosomes into the cytoplasm, and S. aureus–induced host cell death [18]. We have previously demonstrated that α-hemolysin (Hla), which is a pore-forming toxin secreted by S. aureus [19], [20], is the factor responsible for the autophagic response induced by this pathogen in the host cell [21]. In addition, we have shown that this autophagic response induced by Hla occurs via a “non canonical" pathway, which is independent of Beclin1 and PI3K, but requires Atg5 [21]. Also, we have demonstrated that the LC3-labeled vesicles generated by the toxin are non-acidic and non-degradative compartments, indicating that somehow the toxin impedes the maturation of these autophagic structures [21]. In the present study, we have analyzed the signaling mechanisms that regulate the Hla-induced autophagy. We have identified some of the molecular components involved in this pathway and determined their participation in the regulation of the autophagic response generated by the toxin.

Results

cAMP Inhibits the Autophagic Response Induced by α-Hemolysin via a PKA-Independent Pathway

We have previously shown that the autophagic response induced by the toxin α-hemolysin (Hla) was not suppressed by the classical autophagy inhibitors 3-mehtyladenine or wortmannin, suggesting that this process occurs independently of PI3Kinase activation [21]. Thus, we were interested in determining whether other pathways might be involved in the regulation of this “non-canonical" autophagic response. In a recent publication, it was shown that cAMP-dependent protein kinase A (PKA) activation by cAMP is able to inhibit the autophagy pathway through LC3 phosphorylation [22] (Figure S1A). In order to determine if this pathway regulates the autophagic activation induced by alpha-toxin, we analyzed this process in stable transfected CHO cells overexpressing GFP-LC3. The protein LC3 is an autophagic marker present in eukaryotic cells as a soluble form (LC3-I) and a membrane-associated form (LC3-II). When autophagy is activated, LC3-I is conjugated to phosphatidylethanolamine to generate LC3-II, which localizes to autophagosomal membranes [5]. CHO cells overexpressing GFP-LC3 were incubated in complete medium, with or without the toxin or subjected to starvation conditions, in the absence or presence of dbcAMP, a permeable cyclic AMP (cAMP) analog. As shown in Figure 1A, cAMP caused a marked inhibition in the autophagic response induced by the toxin, as indicated by a decrease in LC3-positive vesicles (Panel f). In contrast, and to our surprise, just a little decrease in starvation-induced autophagy was observed (Panel e). The quantification of the percentage of cells presenting LC3 puncta upon incubation in the different conditions is shown in the right panel.
Figure 1

cAMP inhibits Hla-induced autophagy.

(A) GFP-LC3 CHO cells were preincubated with 1 mM dybutiryl cAMP (+dbcAMP, panels d, e, and f) for 30 min and then were treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv) in the continuous presence of dbcAMP. Cells without any treatment were used as control (−dbcAMP, panels a, b, and c). Cells were immediately analyzed by confocal microscopy. A quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions is shown in the right panel (n = 100 cells/condition, * p<0.05 paired Student's t-test). These data are representative of three independent experiments. (B) GFP-LC3 CHO cells were incubated with complete medium in the absence (−dbcAMP) or presence of dbcAMP (+dbcAMP) and treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv) with (lower panel) or without (upper panel) bafilomycin A1 to block lysosomal degradation. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of three independent experiments. (C) The band intensities of two independent experiments were quantificated with the Adobe Photoshop program, and normalized against tubulin. * p<0.05 (paired Student's t-test).

cAMP inhibits Hla-induced autophagy.

(A) GFP-LC3 CHO cells were preincubated with 1 mM dybutiryl cAMP (+dbcAMP, panels d, e, and f) for 30 min and then were treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv) in the continuous presence of dbcAMP. Cells without any treatment were used as control (−dbcAMP, panels a, b, and c). Cells were immediately analyzed by confocal microscopy. A quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions is shown in the right panel (n = 100 cells/condition, * p<0.05 paired Student's t-test). These data are representative of three independent experiments. (B) GFP-LC3 CHO cells were incubated with complete medium in the absence (−dbcAMP) or presence of dbcAMP (+dbcAMP) and treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv) with (lower panel) or without (upper panel) bafilomycin A1 to block lysosomal degradation. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of three independent experiments. (C) The band intensities of two independent experiments were quantificated with the Adobe Photoshop program, and normalized against tubulin. * p<0.05 (paired Student's t-test). Next, we performed a Western blot assay to analyze the processing of LC3. CHO GFP-LC3 cells were incubated in complete medium, with or without the toxin, or subjected to starvation, with or without dbcAMP and in the presence (Figure 1B, lower panel) or the absence (Figure 1B, upper panel) of bafilomycin A1, an inhibitor of the H+ ATPase pump and autophagosome/lysosome fusion. In agreement with the results mentioned above, a decreased level of lipidated LC3 protein was detected in cells incubated with Hla in the presence of dbcAMP, even with bafilomycin A1 (Figure 1B). A quantification of the intensity of the bands is shown in Figure 1C. To corroborate these results, endogenous LC3 was also detected after the different conditions and similar results were obtained (Figure S2A). In order to address whether PKA participates in cAMP-dependent inhibition of the toxin response, we incubated the cells with H89, a PKA inhibitor, in the presence or absence of dbcAMP (Figure 2A). As shown in Figure 2A, H89 was unable to revert the autophagy inhibition induced by dbcAMP in cells treated with the toxin (Panel c). In addition, we overexpressed a dominant-negative PKA regulatory subunit mutated in both sites A and B of the cAMP-binding domain [23]. This dominant negative mutant of the regulatory subunit of PKA cannot be activated by cAMP. Similar to the results obtained with H89, overexpression of this PKA inactive mutant was unable to antagonize the inhibitory effect of dbcAMP in the autophagic response induced by alpha toxin (data not shown). These results indicate that PKA is not participating in the cAMP-dependent inhibition of Hla-induced autophagy. In addition, H89 alone did not affect the autophagic response in either conditions (Figure 2A, Panels e and f). The quantification of the percentage of cells presenting LC3 puncta upon treatment with the different conditions is depicted in Figure 2B. To verify the activity of H89, we analyzed the phosphorylation of CREB, which is a PKA substrate, in cells stimulated with cAMP in the presence or absence of H89. As shown in Figure 2C, H89 decreased the phosphorylation of CREB, confirming that the PKA inhibitor is active in our system. These results indicate that cAMP is acting via a PKA-independent pathway.
Figure 2

PKA inhibition does not affect the autophagic response induced by Hla.

(A) GFP-LC3 CHO cells were preincubated for 30 min with 10 µM H89, a PKA inhibitor, in the presence (panels a, b, and c) or absence (panels d, e, and f) of 1 mM dbcAMP. Subsequently, they were incubated for 2 h in starvation medium (Stv, panels b and e) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla, panels c and f) in full nutrient media. Cells without any treatment were used as control (Ctr, panels a and d). Cells were finally analyzed by confocal microscopy. Images are representative of three independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions. ** p<0.01 (paired Student's t-test, n = 100 cells/condition). These data are representative of two independent experiments. (C) GFP-LC3 CHO cells were preincubated for 30 min in the presence or absence of 10 µM H89, and then they were incubated for 2 h with 1 mM dbcAMP to verify the activity of H89. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-phosphoCREB and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. The band intensities were quantified with the Adobe Photoshop program (lower panel). These data are representative of two independent experiments.

PKA inhibition does not affect the autophagic response induced by Hla.

(A) GFP-LC3 CHO cells were preincubated for 30 min with 10 µM H89, a PKA inhibitor, in the presence (panels a, b, and c) or absence (panels d, e, and f) of 1 mM dbcAMP. Subsequently, they were incubated for 2 h in starvation medium (Stv, panels b and e) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla, panels c and f) in full nutrient media. Cells without any treatment were used as control (Ctr, panels a and d). Cells were finally analyzed by confocal microscopy. Images are representative of three independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions. ** p<0.01 (paired Student's t-test, n = 100 cells/condition). These data are representative of two independent experiments. (C) GFP-LC3 CHO cells were preincubated for 30 min in the presence or absence of 10 µM H89, and then they were incubated for 2 h with 1 mM dbcAMP to verify the activity of H89. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-phosphoCREB and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. The band intensities were quantified with the Adobe Photoshop program (lower panel). These data are representative of two independent experiments.

EPAC and Rap2b Negatively Regulates the Autophagy Induced by α-Hemolysin

cAMP has traditionally been thought to act exclusively through PKA, but at present, cAMP is also known to directly regulate ion channels and the ubiquitous protein EPAC (exchange protein activated by cAMP), a cAMP-regulated effector that is a guanine nucleotide exchange factor (GEF) for the low molecular weight GTPase, Rap [24] (Figure S1A). 8-pCPT-2′-O-Me-cAMP (8-pCPT-cAMP) is a cAMP analog that specifically activates EPAC. Recently published studies demonstrate that 8-pCPT-cAMP is a useful tool to assess atypical actions of cAMP that are PKA-independent [25]. Thus, we next assessed the effect of 8-pCPT-cAMP on the autophagic response induced either by the toxin or by starvation. Similar to dbcAMP, 8-pCPT-cAMP was able to abolish the autophagic response upon α-hemolysin-treatment but did not substantially affect starvation-induced autophagy (Figure 3A). Thus, cAMP-induced EPAC activation seems to be sufficient to inhibit the autophagic response generated by Hla.
Figure 3

EPAC activation inhibits the Hla-dependent autophagy.

(A) GFP-LC3 CHO cells were preincubated with 10 µM 8-pCPT-2′-O-Me-cAMP (8-pCPT) for 30 min and then they were treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv). Cells without any treatment were used as control. Cells were immediately analyzed by confocal microscopy. Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions is shown in the right panel (n = 50 cells/condition). These data are representative of two independent experiments. (B) CHO cells were cotransfected with GFP-LC3 and myc-EPAC wt (left panel) or myc-ΔEPAC (right panel). Twenty-four hours after transfection they were incubated for 2 h in starvation medium (Stv) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (C) Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions (n = 20 cells/condition). These data are representative of two independent experiments.

EPAC activation inhibits the Hla-dependent autophagy.

(A) GFP-LC3 CHO cells were preincubated with 10 µM 8-pCPT-2′-O-Me-cAMP (8-pCPT) for 30 min and then they were treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv). Cells without any treatment were used as control. Cells were immediately analyzed by confocal microscopy. Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions is shown in the right panel (n = 50 cells/condition). These data are representative of two independent experiments. (B) CHO cells were cotransfected with GFP-LC3 and myc-EPAC wt (left panel) or myc-ΔEPAC (right panel). Twenty-four hours after transfection they were incubated for 2 h in starvation medium (Stv) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (C) Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions (n = 20 cells/condition). These data are representative of two independent experiments. To ascertain the participation of the Rap exchange factor EPAC in the Hla-induced autophagic pathway, CHO cells were cotransfected with GFP-LC3 and Myc-EPAC wt or the Myc-ΔEPAC mutant, a constitutively active GEF mutant that maximally activates Rap even in the absence of cAMP stimulation [26]. Subsequently, the cells were incubated in complete medium (with or without 10 µg/ml of α-hemolysin) or under starvation conditions, a physiological inducer of autophagy. As shown in Figure 3B, overexpression of either EPAC wt (left panels) or its active mutant (ΔEPAC, right panels) was able to inhibit the Hla-induced autophagic response, but had no inhibitory effect in the autophagy induced by starvation. The quantification of the percentage of cells presenting LC3 puncta upon incubation in the different conditions is shown in Figure 3C. As control, CHO cells were cotransfected with GFP-LC3 and RFP-vector and treated as described above. As expected, both autophagy inducers (i.e., starvation and rapamycin), as well as treatment with the toxin, caused the typical LC3 punctate distribution (Figure S3A and S3B). Thus, taken together, these results indicate that EPAC regulates the autophagy induced by the toxin and when activated is able to inhibit this autophagic response. In order to corroborate whether the EPAC pathway is responsible for the regulation of autophagy activation induced by Hla, we analyzed a downstream component of this pathway, the small GTPase Rap2b. For this purpose, CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b wt or the GFP-Rap2b ΔAAX mutant, which cannot be lipidated because it has a deletion in its C-terminal motif, losing both membrane localization and activity. It has been shown that deletion of the CAAX motif abolishes plasma membrane localization and compromises the biological function of many Ras-related GTPases [27]. The transfected cells were incubated in complete medium (in the presence or the absence of 10 µg/ml of α-hemolysin), under starvation conditions, or with 50 ng/µl of rapamycin, a pharmacological inducer of autophagy (Figure 4A). As control, CHO cells were cotransfected with RFP-LC3 and GFP-vector and treated as described above. As expected, both autophagy inducers (i.e., starvation and rapamycin), as well as treatment with the toxin, caused the typical LC3 punctate distribution (Figure S3C and S3D). As shown in Figure 4A, overexpression of Rap2b wt was able to inhibit the autophagic response induced by the toxin, but had no effect in the autophagy activated by starvation or rapamycin. In contrast, overexpression of the mutant Rap2b ΔAAX did not affect toxin-induced autophagy, indicating that Rap2b participates in the pathway that regulates the autophagy induced by α-hemolysin preventing this autophagic response. Of note, overexpression of Rap2b ΔAAX decreased the autophagy induced by starvation and rapamycin, suggesting that Rap2b might be a common link between both the “non-canonical" autophagy pathway induced by the toxin and the classical autophagic pathway induced by starvation. The quantification of the percentage of cells presenting LC3 puncta subjected to different treatments is shown in Figure 4B. To corroborate these results, we performed a Western blot assay to analyze the processing of LC3. CHO cells were transfected with Rap2b wt or Rap2b ΔAAX and incubated in complete medium (with or without the toxin) with rapamycin or subjected to starvation conditions in the presence or absence of bafilomycin A1. In agreement with the results mentioned above, a decreased level of lipidated LC3 protein was detected in cells overexpressing Rap2b wt and incubated with Hla, whereas no effect was observed in cells overexpressing the inactive mutant Rap2b ΔAAX (Figure 4C). A quantification of the bands intensities is shown in Figure 4D.
Figure 4

Rap2b negatively regulates the autophagic response induced by the toxin.

(A) CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b wt (left panel) or GFP-Rap2b ΔAAX (right panel). Twenty-four hours after transfection, they were incubated for 2 h in starvation medium (Stv), with 50 ng/µl of rapamycin (Rapa) in full nutrient media, or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of three independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions is shown. * p<0.05, ** p<0.01 (paired Student's t-test, n = 50 cells/condition). These data are representative of three independent experiments. (C) CHO cells were transfected with GFP-Rap2b wt or GFP-Rap2b ΔAAX and incubated with complete medium without (Ctr) or with 10 µg/ml of α-hemolysin (Hla) for 4 h, with 50 ng/µl of rapamycin (Rapa) or subjected to starvation conditions (Stv) for 2 h in the absence or presence of bafilomycin A1. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of two independent experiments. (D) Quantification of the Western blot bands intensities of two independent experiments with the Adobe Photoshop program.

Rap2b negatively regulates the autophagic response induced by the toxin.

(A) CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b wt (left panel) or GFP-Rap2b ΔAAX (right panel). Twenty-four hours after transfection, they were incubated for 2 h in starvation medium (Stv), with 50 ng/µl of rapamycin (Rapa) in full nutrient media, or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of three independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions is shown. * p<0.05, ** p<0.01 (paired Student's t-test, n = 50 cells/condition). These data are representative of three independent experiments. (C) CHO cells were transfected with GFP-Rap2b wt or GFP-Rap2b ΔAAX and incubated with complete medium without (Ctr) or with 10 µg/ml of α-hemolysin (Hla) for 4 h, with 50 ng/µl of rapamycin (Rapa) or subjected to starvation conditions (Stv) for 2 h in the absence or presence of bafilomycin A1. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of two independent experiments. (D) Quantification of the Western blot bands intensities of two independent experiments with the Adobe Photoshop program. To determine whether depletion of Rap2b affects the starvation- or Hla-iduced autophagy, we used a Rap2b siRNA. HeLa cells were cotransfected with GFP-LC3 and Rap2b siRNA or with an irrelevant siRNA, and then they were incubated in complete medium (in the presence or the absence of 10 µg/ml of α-hemolysin) with rapamycin or under starvation conditions (Figure 5A). As shown in Figure 5A, knockdown of Rap2b was able to decrease the autophagic response induced by starvation and rapamycin, but did not affect the autophagy activated by the toxin. The quantification of the percentage of cells presenting LC3 puncta subjected to the different treatments is shown in Figure 5B. The effective knockdown of Rap2b was determined by Western blot as shown in Figure 5C. To corroborate these results, we performed a Western blot assay to analyze the processing of LC3. HeLa cells were transfected with Rap2b siRNA or irrelevant siRNA and subjected to the different treatments as indicated above. As shown in Figure 5D, a decreased level of lipidated LC3 protein was detected in cells transfected with Rap2b siRNA and incubated with rapamycin or under starvation conditions, but the levels were not affected in cells treated with the toxin. A quantification of the intensity of the bands is shown in Figure 5E.
Figure 5

Rap2b knockdown does not affect Hla-induced autophagy.

(A) HeLa cells were cotransfected with Rap2b siRNA and GFP-LC3 (right panel) or irrelevant siRNA and GFP-LC3 (left panel). Forty-eight hours after transfection, they were incubated for 2 h in starvation medium (Stv), with 50 ng/µl of rapamycin (Rapa) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions. Data correspond to two independent experiments (n = 50 cells/condition). (C) Upper panel: The knockdown of Rap2b was determined by Western blot as indicated in Materials and Methods. Lower panel: The band intensities of two independent experiments were quantified with the Adobe Photoshop program, and normalized against tubulin. * p<0.05 (paired Student's t-test). (D) HeLa cells were cotransfected with GFP-LC3 and Rap2b siRNA or an irrelevant siRNA and incubated for 4 h with complete medium in the absence (Ctr) or presence of 10 µg/ml of α-hemolysin (Hla), with 50 ng/µl of rapamycin (Rapa) or subjected to starvation conditions (Stv) for 2 h. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of two independent experiments. (E) The band intensities of two independent experiments were quantified with the Adobe Photoshop program, and normalized against tubulin. * p<0.05 (paired Student's t-test).

Rap2b knockdown does not affect Hla-induced autophagy.

(A) HeLa cells were cotransfected with Rap2b siRNA and GFP-LC3 (right panel) or irrelevant siRNA and GFP-LC3 (left panel). Forty-eight hours after transfection, they were incubated for 2 h in starvation medium (Stv), with 50 ng/µl of rapamycin (Rapa) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions. Data correspond to two independent experiments (n = 50 cells/condition). (C) Upper panel: The knockdown of Rap2b was determined by Western blot as indicated in Materials and Methods. Lower panel: The band intensities of two independent experiments were quantified with the Adobe Photoshop program, and normalized against tubulin. * p<0.05 (paired Student's t-test). (D) HeLa cells were cotransfected with GFP-LC3 and Rap2b siRNA or an irrelevant siRNA and incubated for 4 h with complete medium in the absence (Ctr) or presence of 10 µg/ml of α-hemolysin (Hla), with 50 ng/µl of rapamycin (Rapa) or subjected to starvation conditions (Stv) for 2 h. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of two independent experiments. (E) The band intensities of two independent experiments were quantified with the Adobe Photoshop program, and normalized against tubulin. * p<0.05 (paired Student's t-test). Next, we were interested in addressing whether cAMP was able to inhibit the Hla-induced autophagy even in cells overexpressing Rap2b ΔAAX. Thus, CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b ΔAAX, and then they were treated with Hla or starvation medium in the presence or absence of cAMP (Figure 6A). Our results indicate that cAMP was unable to inhibit the autophagy induced by the toxin in cells overexpressing the Rap2b negative mutant, indicating that the inhibitory effect of cAMP requires a functional Rap2B (Figure 6A). CHO cells cotransfected with RFP-LC3 and GFP-vector and treated as above displayed the expected autophagic response induced by Hla or by starvation (data not shown). The quantification of the percentage of cells presenting LC3 puncta upon incubation in the different conditions is shown in Figure 6B.
Figure 6

cAMP cannot inhibit the autophagy induced by the toxin in cells overexpressing the Rap2b negative mutant.

(A) CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b ΔAAX. Twenty-four hours after transfection they were incubated for 2 h in starvation medium (Stv) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla) in the presence (right panels) or absence of 1 mM dbcAMP (left panels). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions. These data are representative of two independent experiments.

cAMP cannot inhibit the autophagy induced by the toxin in cells overexpressing the Rap2b negative mutant.

(A) CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b ΔAAX. Twenty-four hours after transfection they were incubated for 2 h in starvation medium (Stv) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla) in the presence (right panels) or absence of 1 mM dbcAMP (left panels). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions. These data are representative of two independent experiments. Taken together, these results clearly indicate that Rap2b is a key participant in the regulation of autophagy induced by α-hemolysin, and it is likely that this small GTPase needs to be inactivated to allow this autophagic response.

Inhibition of Calpains Allows Autophagy Activation Induced by the Toxin

Rap2b is known to produce an increase of cytoplasmic calcium through a rise in IP3 [28]. Calpains are a family of cysteine-proteases that are activated by intracellular calcium. When calpains are activated, they are able to cleave Atg5, inhibiting autophagy in basal conditions [29]. In order to demonstrate the participation of calpains in this pathway we used calpeptin, a calpains inhibitor. CHO cells overexpressing GFP-LC3 were incubated with dbcAMP in the presence or the absence of calpeptin. Our results indicate that while cAMP alone was able to inhibit the Hla-induced autophagic response, calpeptin-preincubation prevented its inhibitory effect (Figure 7A, Panels k and l). These results suggest that during the autophagic response induced by Hla calpains are inhibited. The quantification of the percentage of cells presenting LC3 puncta upon treatment with the different conditions is shown in Figure 7B. In addition, the processing of LC3 was analyzed by Western blot. CHO cells were preincubated with dbcAMP, calpeptin, or calpeptin+dbcAMP, and then they were incubated in complete medium with or without the toxin. In agreement with the results mentioned above, calpeptin-preincubation prevented the inhibitory effect of dbcAMP in the Hla-induced autophagy, whereas a decreased level of lipidated LC3 protein was detected in cells preincubated with dbcAMP alone and treated with Hla (Figure 7C). A quantification of the bands' intensities is shown in Figure 7C (lower panel). Thus, these results suggest that the activation of calpains by cAMP leads to the inhibition of the Hla-induced autophagy. Therefore, calpains might act as negative regulators of this particular form of toxin-induced autophagic response.
Figure 7

Calpain inactivation hampers the inhibitory effect of dbcAMP.

(A) GFP-LC3 CHO cells were preincubated for 30 min with 10 µM of calpeptin (a calpain inhibitor, panels b, f, and j), with 1 mM dbcAMP (panels d, h and l), or with Calpeptin+dbcAMP (panels c, g, and k). Afterwards, they were incubated for 2 h in starvation medium (Stv, panels e, f, g, and h) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla, panels i, j, k, and l). Cells without any treatment were used as control (Ctr, panels a, b, c and d). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions. * p<0.05 (paired Student's t-test, n = 100 cells/condition). These data are representative of two independent experiments. (C) Upper panel: CHO cells were preincubated for 30 min with 10 µM of calpeptin, with 1 mM dbcAMP, or with calpeptin+dbcAMP, and then they were incubated for 4 h in complete medium in the presence (Hla) or absence (Ctr) of α-hemolysin. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody. The bands were subsequently developed with an enhanced chemiluminescence detection kit. Lower panel: Quantification of the band intensities with the Adobe Photoshop program. * p<0.05 (paired Student's t-test). These data are representative of three independent experiments.

Calpain inactivation hampers the inhibitory effect of dbcAMP.

(A) GFP-LC3 CHO cells were preincubated for 30 min with 10 µM of calpeptin (a calpain inhibitor, panels b, f, and j), with 1 mM dbcAMP (panels d, h and l), or with Calpeptin+dbcAMP (panels c, g, and k). Afterwards, they were incubated for 2 h in starvation medium (Stv, panels e, f, g, and h) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla, panels i, j, k, and l). Cells without any treatment were used as control (Ctr, panels a, b, c and d). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions. * p<0.05 (paired Student's t-test, n = 100 cells/condition). These data are representative of two independent experiments. (C) Upper panel: CHO cells were preincubated for 30 min with 10 µM of calpeptin, with 1 mM dbcAMP, or with calpeptin+dbcAMP, and then they were incubated for 4 h in complete medium in the presence (Hla) or absence (Ctr) of α-hemolysin. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody. The bands were subsequently developed with an enhanced chemiluminescence detection kit. Lower panel: Quantification of the band intensities with the Adobe Photoshop program. * p<0.05 (paired Student's t-test). These data are representative of three independent experiments.

cAMP, EPAC, and Rap2b Negatively Regulate the Autophagic Response Induced upon Infection with S. aureus

We have previously shown that a population of internalized S. aureus recruits GFP-LC3 to their containing phagosomes and that this recruitment was dependent on the production of α-hemolysin [21]. To corroborate the participation of the above pathway in the regulation of autophagy induced by the toxin, we used different S. aureus strains: a wild-type strain (wt), a mutant deficient for α-hemolysin (Hla−), and the Hla(−) mutant complemented with an α-hemolysin plasmid (Hla(−)+pHla). GFP-LC3 CHO cells were preincubated with dbcAMP and infected for 4 h with the different S. aureus strains. Cells were then incubated with TOPRO, a DNA marker, to label the bacteria. As shown in Figure 8A, right panels, cAMP caused inhibition of autophagy induced either by S. aureus wt or by the complemented Hla(−) mutant. As control, autophagy activation by the wt and the complemented Hla(−) mutant strains in the absence of dbcAMP is also depicted (Figure 8A, left panels). The quantification of the percentage of infected cells presenting LC3 puncta upon treatment with or without dbcAMP is shown in Figure 8B.
Figure 8

cAMP inhibits S. aureus–induced autophagy.

(A) GFP-LC3 CHO cells were preincubated with 1 mM dybutiryl cAMP (+dbcAMP) for 30 min and then were infected for 4 h in the presence of db cAMP with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−) +pHla). Cells without any treatment were used as control (−dbcAMP). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods, and immediately visualized by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation in the different conditions. * p<0.05, ** p<0.01 (paired Student's t-test, n = 50 cells/condition). These data are representative of two independent experiments. (C) Quantification of the number of CFU/ml of CHO cells infected for 3 h with the wt strain of S. aureus, the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid in the absence or presence of cAMP. * p<0.05 (paired Student's t-test). These data are representative of two independent experiments.

cAMP inhibits S. aureus–induced autophagy.

(A) GFP-LC3 CHO cells were preincubated with 1 mM dybutiryl cAMP (+dbcAMP) for 30 min and then were infected for 4 h in the presence of db cAMP with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−) +pHla). Cells without any treatment were used as control (−dbcAMP). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods, and immediately visualized by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation in the different conditions. * p<0.05, ** p<0.01 (paired Student's t-test, n = 50 cells/condition). These data are representative of two independent experiments. (C) Quantification of the number of CFU/ml of CHO cells infected for 3 h with the wt strain of S. aureus, the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid in the absence or presence of cAMP. * p<0.05 (paired Student's t-test). These data are representative of two independent experiments. We have previously shown that autophagy inhibition decreases bacterial replication [21], so next we determined whether cAMP affects intracellular bacterial grown. For this purpose, CHO cells were infected for 3 h with the wt strain of S. aureus, the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid. After the infection, cells were lysed and plated for colony forming units (CFU) quantification (Figure 8C). Interestingly, a marked decrease in bacterial replication was observed after treatment with cAMP, corroborating that autophagy is necessary for efficient bacterial replication and demonstrating that elevated levels of cAMP negatively affects S. aureus intracellular growth. In order to corroborate the participation of EPAC and Rap2b in this autophagy regulation, CHO cells were cotransfected with GFP-LC3 and myc-EPAC wt or myc-ΔEPAC (Figure 9A); or with RFP-LC3 and GFP-Rap2b wt or GFP-Rap2b ΔAAX (Figure 10A). Cells were then incubated with TOPRO, to label the bacteria. As shown in Figure 9A, overexpression of EPAC wt (upper panels) or its active mutant ΔEPAC (lower panels) was sufficient to suppress the autophagic response induced by S. aureus wt and the complemented Hla(−) mutant (Hla(−)+pHla). The quantification of the percentage of infected cells overexpresing EPAC presenting LC3 puncta is shown in Figure 9B. As control, CHO cells were cotransfected with GFP-LC3 and RFP-vector and infected as described above. As expected, both the wt strain and the complemented Hla(−) mutant caused the typical LC3 recruitment (Figure S4).
Figure 9

EPAC overexpression suppresses the autophagic response induced by S. aureus.

CHO cells were cotransfected with GFP-LC3 and myc-EPAC wt (upper panel) or myc-ΔEPAC (lower panel). Twenty-four hours after transfection, they were infected for 4 h with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−)+pHla). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods and immediately visualized by confocal microscopy. Images are representative of three independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta upon the infection. These data are representative of three independent experiments. (C) Quantification of the percentage of bacteria decorated with EPAC in cells infected with S. aureus. ** p<0.01 (paired Student's t-test, n = 20 cells/condition). These data are representative of three independent experiments.

Figure 10

Rap2b inhibits the autophagy induced by S. aureus.

(A) CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b wt (upper panel) or GFP-Rap2b ΔAAX (lower panel). Twenty-four hours after transfection, they were infected for 4 h with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−)+pHla). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods and immediately visualized by confocal microscopy. These data are representative of three independent experiments. (B) Quantification of the percentage of infected cells presenting LC3 puncta upon the infection. * p<0.05, *** p<0.001 (paired Student's t-test, n = 50 cells/condition). These data are representative of three independent experiments. (C) Quantification of the percentage of bacteria decorated with Rap2b wt upon the infection. ** p<0.01 (paired Student's t-test, n = 30 cells/condition). These data are representative of three independent experiments.

EPAC overexpression suppresses the autophagic response induced by S. aureus.

CHO cells were cotransfected with GFP-LC3 and myc-EPAC wt (upper panel) or myc-ΔEPAC (lower panel). Twenty-four hours after transfection, they were infected for 4 h with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−)+pHla). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods and immediately visualized by confocal microscopy. Images are representative of three independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta upon the infection. These data are representative of three independent experiments. (C) Quantification of the percentage of bacteria decorated with EPAC in cells infected with S. aureus. ** p<0.01 (paired Student's t-test, n = 20 cells/condition). These data are representative of three independent experiments.

Rap2b inhibits the autophagy induced by S. aureus.

(A) CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b wt (upper panel) or GFP-Rap2b ΔAAX (lower panel). Twenty-four hours after transfection, they were infected for 4 h with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−)+pHla). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods and immediately visualized by confocal microscopy. These data are representative of three independent experiments. (B) Quantification of the percentage of infected cells presenting LC3 puncta upon the infection. * p<0.05, *** p<0.001 (paired Student's t-test, n = 50 cells/condition). These data are representative of three independent experiments. (C) Quantification of the percentage of bacteria decorated with Rap2b wt upon the infection. ** p<0.01 (paired Student's t-test, n = 30 cells/condition). These data are representative of three independent experiments. Consistently, overexpression of Rap2b was also able to inhibit the autophagy induced by the bacteria (Figure 10A, upper panels). In contrast, overexpression of the negative mutant Rap2b ΔAAX had not effect in the autophagic response induced by S. aureus (Figure 10A, lower panels). The quantification of the percentage of infected cells overexpresing Rap2b presenting LC3 puncta is shown in Figure 10B. Strikingly, a remarkable recruitment of both EPAC and Rap2b to the bacteria-containing phagosome was observed (insets in Figures 9A and 10A). The quantification of the percentage of bacteria decorated with EPAC or Rap2b upon the infection is shown in Figure 9C and 10C. These data indicate that approximately 40%–50% of the bacteria-containing phagosomes showed association with either EPAC or Rap2B. The association of both proteins to the S. aureus phagosomal compartment was only partly decreased in phagosomes containing the Hla-deficient strain. For this reason, we determined the localization of endogenous EPAC or Rap2b. CHO cells were infected with the different S. aureus strains and EPAC or Rap2b were detected by indirect immunofluorescense (Figure S5). Interestingly, we observed that the Hla-deficient strain was unable to recruit either EPAC or Rap2b, suggesting that the partial recruitment of the overexpressed EPAC and Rap2b by the Hla (−) strain is likely due to the excess of molecules present in the transfected cells. Next, we analyzed the colocalization between LC3 and endogenous EPAC or Rap2b. For this purpose, CHO GFP-LC3 cells were infected as above and the proteins were detected by indirect immunofluorescense (Figure S6). Interestingly, neither EPAC nor Rap2b colocalized with LC3, suggesting that the population of bacteria that recruit EPAC/Rap2b does not recruit LC3 or that both proteins are differentially recruited on time. Taken together, these results clearly confirm that the identified molecular components involved in the autophagic pathway induced by the purified toxin also participate in the autophagic response upon infection with S. aureus, negatively regulating the autophagic response exerted by this pathogen.

Active Rap2b Are Downregulated to Allow the Autophagic Response Induced by Hla and upon Infection with S. aureus

The results shown above clearly indicate that cAMP and Rap2b are negative regulators of the autophagic activation induced by the toxin and by the infection with S. aureus. In order to determine how the bacteria and the toxin are able to regulate this autophagic pathway, we analyzed the levels of active Rap2b present in the cells. For this purpose, HeLa cells were incubated with the toxin or infected for 4 h with S. aureus wt strain or the mutant deficient in Hla. Then, the cells were lysed and GTP-bound Rap2b was pulled down with immobilized Ral-GDS-RBD, a cassette that is able to bind GTP-Rap proteins [30]. The amount of protein pulled down was determined by Western blot assay, using a polyclonal Rap2b antibody. As shown in Figure 11B, the levels of active Rap2b decreased in response to Hla treatment or when the cells were infected with S. aureus wt strain. However, no differences in the total amount of cellular Rap2b in the cells subjected to the different conditions were observed (Figure 11A). These results suggest that the toxin induces a decrease in the amount of active Rap2b, likely by decreasing the levels of intracellular cAMP, to allow autophagy induction, a response that favors pathogen intracellular survival as previously demonstrated.
Figure 11

Active Rap2b is decreased to allow the autophagy response induced by Hla and S. aureus.

(A) HeLa cells were incubated for 4 h with complete medium in the presence (Hla) or absence (Ctr) of 10 µg/ml α-hemolysin or they were infected for 4 h with the wt strain of S. aureus (wt) or the α-hemolysin deficient mutant (Hla−). Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-Rap2b and the corresponding HRP-labeled secondary antibody. The bands were subsequently developed with an enhanced chemiluminescence detection kit. A quantification of the bands intensities with the Adobe Photoshop program is shown in the lower panel. These data are representative of two independent experiments. (B) HeLa cells were incubated for 4 h with complete medium in the presence (Hla) or absence (Ctr) of 10 µg/ml α-hemolysin or they were infected for 4 h with the wt strain of S. aureus (wt) or the α-hemolysin deficient mutant (Hla−). Cells were disrupted and whole cell lysates were subjected to pull-down assays using GST-Ral-GDS-RBD-sepharose. The levels of GTP-bound Rap2b were determined as was described in Materials and Methods by Western blot analysis using a rabbit anti-Rap2b and the corresponding HRP-labeled secondary antibody. The bands were subsequently developed with an enhanced chemiluminescence detection kit. The band intensities were quantificated with the Adobe Photoshop program is shown in the lower panel. * p<0.05 (paired Student's t-test). These data are representative of two independent experiments.

Active Rap2b is decreased to allow the autophagy response induced by Hla and S. aureus.

(A) HeLa cells were incubated for 4 h with complete medium in the presence (Hla) or absence (Ctr) of 10 µg/ml α-hemolysin or they were infected for 4 h with the wt strain of S. aureus (wt) or the α-hemolysin deficient mutant (Hla−). Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-Rap2b and the corresponding HRP-labeled secondary antibody. The bands were subsequently developed with an enhanced chemiluminescence detection kit. A quantification of the bands intensities with the Adobe Photoshop program is shown in the lower panel. These data are representative of two independent experiments. (B) HeLa cells were incubated for 4 h with complete medium in the presence (Hla) or absence (Ctr) of 10 µg/ml α-hemolysin or they were infected for 4 h with the wt strain of S. aureus (wt) or the α-hemolysin deficient mutant (Hla−). Cells were disrupted and whole cell lysates were subjected to pull-down assays using GST-Ral-GDS-RBD-sepharose. The levels of GTP-bound Rap2b were determined as was described in Materials and Methods by Western blot analysis using a rabbit anti-Rap2b and the corresponding HRP-labeled secondary antibody. The bands were subsequently developed with an enhanced chemiluminescence detection kit. The band intensities were quantificated with the Adobe Photoshop program is shown in the lower panel. * p<0.05 (paired Student's t-test). These data are representative of two independent experiments. A model indicating the two cAMP-dependent pathways involved in the control of autophagy and the effect of different molecules used in this study on the autophagic response induced by Hla and by S. aureus is shown in Figure S1B.

Discussion

In previous studies we have demonstrated that S. aureus induces autophagy activation in infected cells [21]. We presented evidence indicating that S. aureus uses the α-hemolysin to activate the autophagic response, generating LC3-positive vesicles that are unable to mature, interrupting the autophagic flux [21]. These autophagic vesicles, which are non-acidic and non-degradative compartments, are likely used by the bacteria as a replicative niche, escaping then toward the cytoplasm to subsequently infect neighboring cells. We have also shown that the autophagic response induced by Hla does not occur by the classical pathway of autophagy activation. The toxin uses an alternative form to induce autophagy, which is independent of the PI3K/Beclin1 complex but dependent on the autophagic protein Atg5 [21]. In the present study, we have shown that cAMP plays a key role in the Hla-induced autophagic response. Indeed, our results indicate that this response is strongly suppressed by cAMP treatment. cAMP is a classical PKA activator that participates in several cellular process [31]. Recently, it has been demonstrated that PKA participates in autophagy regulation induced by the rapamycin-mediated inactivation of the TOR pathway [22]. In that report, Charleen Chu and coworkers have shown that, upon activation by cAMP, PKA is able to phosphorylate LC3. This phosphorylation in LC3 prevents autophagy activation, suggesting cAMP as a possible regulator of the autophagic pathway induced by rapamycin [22]. In addition, it has been also shown in the budding yeast S. cerevisiae that elevated levels of Ras/PKA activity prevented the autophagy activity induced by either nitrogen starvation or by the pharmacological inducer rapamycin [32]. It was proposed that this signaling pathway is controlling an activity required during the early stages of the autophagic pathway. However, in our work, we have demonstrated by employing the widely used PKA inhibitor H89 [33] (Figure 2), and by overexpressing a dominant negative mutant of the regulatory subunit of PKA [23] (data not shown), that PKA does not seem to participate in cAMP inhibition of the autophagic pathway induced by the toxin. For many years, cAMP signaling was solely associated with PKA. However, novel cAMP sensors have come to light and they regulate many physiological processes either in concert with PKA or by themselves. It is known that cAMP is able to stimulate the cAMP-activated guanine exchange factor EPAC, which specifically turns on the monomeric G protein Rap [24], [34], [35]. EPAC proteins are known to control a range of diverse effectors and to regulate several pivotal processes. Here, we have shown that EPAC and its effector Rap2b participate in the regulation of Hla-induced autophagy. We have demonstrated that the direct activation of EPAC by cAMP or the overexpression of EPAC/Rap2b is sufficient to inhibit the autophagy response induced by the toxin (Figures 3, 4, and 6). Interestingly, Rubinsztein and collaborators [28] have shown that drugs that signal via the imidazoline type 1 receptor (I1R), such as clonidine, act by reducing cAMP levels. The compounds enhanced A53T α-synuclein clearance and decreased toxic protein aggregation by activating an m-TOR independent autophagy. In addition, these I1R agonists signal via cAMP/Epac/Rap2b/PLC. When activated by cAMP, EPAC in turn activates Rap2b, which, through PLCε and an increase in the cytoplasmic levels of IP3, induces exit of calcium from the endoplasmic reticulum. Rise in intracytosolic Ca2+ activates the calcium-dependent cysteine-protease calpains [36]. Indeed, it was shown that calpain inhibitors and siRNA knockdown of either calpain 1 or calpain 2 increased LC3-labeled autophagosomes [28]. Likewise, Junying Yuan and coworkers have shown that flurispirene, a compound that inhibits calcium flux, activates autophagy [29]. These authors have demonstrated that inactivation of calpain 1, which in turn is able to cleave Atg5, leads to activation of autophagy by increasing the levels of the Atg5-Atg12 complex required for LC3-lipidation. Consistently, with both reports, we have shown that the inhibition of calpains by the inhibitor calpeptin was sufficient to revert cAMP inhibition of the autophagy induced by Hla (Figure 7). Our results demonstrate, to our knowledge for the first time, that this signaling pathway participates in the regulation of the Hla-induced autophagic response and suggest that the toxin likely controls this pathway to allow autophagy activation, which is beneficial to the bacteria [18], [21]. Additionally, a role for Atg5 in apoptosis has also been demonstrated. Hans-Uwe Simon and collaborators have identified a truncated form of Atg5 of 24 kDa in human neutrophils and Jurkat cells that is generated following different stimuli [37]. They concluded that Atg5 is cleaved by calpain 1 and 2. They also showed that cells overexpressing Atg5 are more sensitive to cell death induced by different apoptotic stimuli and that the silencing of Atg5 reduces this cell death. Interestingly, this truncated Atg5 translocates from cytoplasm to mitochondria and causes cytochrome c release. The truncated form of Atg5 binds to Bcl-xl and may inactivate the Bcl-xl anti-apoptotic activity, promoting apoptotic cell death. These results clearly represent a link between autophagy and apoptosis through the calpain-mediated Atg5 cleavage [37]. Thus, it is tempting to speculate that S. aureus inhibits the calpain-mediated Atg5 cleavage to avoid apoptotic cell death and to favor autophagy activation, which is known to promote bacterial replication and bacterial survival [18]. To confirm the participation of this cAMP/EPAC/Rap2b pathway in the bacterial infection process, we used different S. aureus Hla positive and null strains. We have demonstrated that preincubation with cAMP was also able to inhibit the autophagy activation induced by S. aureus. Similar results were obtained when Rap2b wt and EPAC wt or its constitutively active mutant ΔEPAC were overexpressed. Interestingly, both EPAC and Rap2b were markedly recruited to the membrane of the bacteria-containing phagosome (Figure 9 and Figure 10). Aronoff and collaborators have demonstrated that following treatment of alveolar macrophages with prostaglandin E2, EPAC-1 changes its localization from tubular membranes to the nuclear envelope and late phagosomes [38]. Since it has been shown that 8-pCPT, via EPAC, inhibits H2O2 production and bacterial killing, we propose that EPAC is recruited to the S. aureus phagosomal membrane to suppress its microbicidal capacity, inhibiting the killing of this intraphagosomal pathogen [38], [39]. To the best of our knowledge, our studies are the first to demonstrate the recruitment of EPAC and Rap2b to a pathogen-containing compartment. Additionally, we have observed that those phagosomes that recruit EPAC are not labeled by LC3 (Figure S6). This is consistent with our model that EPAC (and Rap2b) act as an inhibitory molecule of the autophagic response induced by the Hla toxin. Further studies will be necessary to determine whether EPAC recruitment affects pathogen survival. We believe that our findings have important implications in understanding innate immune processes. Experiments are under way in our laboratory to determine how EPAC modulation controls the microbicidal capacity of different bacterial-containing phagosomes. Additionally, our results suggest that S. aureus keeps autophagy under tight control by downregulating levels of active Rap2b (Figure 11), likely to maintain appropriate levels of the Atg5-Atg12 conjugate (Figure S2B). Since cAMP through EPAC activation is able to activate Rap2b, we determined the intracellular cAMP levels by RIA as described in Materials and Methods. We have observed a decrease in cAMP level in cells treated with the toxin or infected with S. aureus wt strain (data not shown). Inhibition of calpain activity as a result of reductions in intracellular Ca2+ might be part of the signal that leads to the activation of autophagy machinery by increasing the levels of a key autophagy signaling molecule such as Atg5. Indeed, we have previously shown that Atg5 is an absolute requirement for the toxin-activated autophagic response [21]. The evidence presented in this report indicates that the complex interplay between cAMP and Ca2+, known to be involved in the control of many cellular processes, may also expand to the regulation of a pathogen-induced autophagic response. We have previously shown that a high concentration of BAPTA-AM (30 µM), an intracellular calcium chelator, is able to avoid the Hla-induced autophagy [21]. This concentration of BAPTA-AM allows the compound to cross the plasma membrane and the membrane of some organelles, chelating not only cytosolic but also intravesicular calcium [40]. Interestingly, we have found that a lower concentration of BAPTA-AM (5 µM), which chelates only the cytosolic calcium [41], allows the autophagic response induced by the toxin (data not shown). It is known that a certain level of intracellular calcium is necessary for autophagosome formation [42], but we believe that an excess of cytosolic calcium leads to activation of the calpains proteases, which in turn could arrest the autophagic response induced by Hla. Thus, is likely that the intracellular calcium concentration is tightly regulated upon infection of S. aureus. Given the fact that S. aureus is a microorganism that causes serious diseases such as pneumonia, endocarditis, osteomyelitis, and wound infections, we believe that knowledge of the signal transduction mechanisms involved in the autophagy response and how these mechanisms enhance the intracellular survival of S. aureus is of seminal importance. The present findings will contribute to our understanding of the molecular mechanisms used by S. aureus to survive in infected cells, a key step in Staphylococcal pathogenicity.

Materials and Methods

Materials

α-MEM and D-MEN cell culture media and fetal calf serum were obtained from Invitrogen, Argentina (Buenos Aires, Argentina). H89 was purchased from LC Laboratory (Massachusetts, USA). A polyclonal rabbit anti-LC3 antibody was purchased from Sigma (Buenos Aires, Argentina). The anti-myc antibody, the anti-Rap2b antibody, and Rap2b siRNA were purchased from Santa Cruz Biotechnology (Buenos Aires, Argentina). All the other reagents were from Sigma (Buenos Aires, Argentina). The anti-phosphoCREB was kindly provided by Dr. Verónica García (Facultad de Ciencias Exactas, UBA, Buenos Aires, Argentina).

Plasmids

pEGFP-LC3 was kindly provided by Dr. Noboru Mizushima (The Tokyo Metropolitan Institute of Medical Science, Japan). The insert encoding the LC3 protein was subcloned into the red fluorescent protein vector (pRFP, kindly provided by Dr. Philip Stahl, Washington University). Briefly, the insert from pEGFP-LC3 was cut with the Bgl II and EcoRI restriction enzymes and subcloned in the corresponding restriction sites of pRFP vector. The pGFP-Rap2B wt and pGFP-Rap2B ΔAAX were kindly provided by Dr. Mauro Torti (University of Pavia, Pavia, Italy). The plasmids pCMV myc-Epac wt and pCMV myc-ΔEpac were kindly provided by Dr. Omar A. Coso (IFIBYNE, Facultad de Ciencias Exactas, UBA, Buenos Aires, Argentina).

Cell Culture and Transfection

CHO cells, an ovary hamster cell line, were grown in α-MEM supplemented with 10% FCS, streptomycin (50 µg/ml), and penicillin (50 U/ml). HeLa human epithelial cells were grown in D-MEM supplemented with 10% FCS, streptomycin (50 µg/ml), and penicillin (50 U/ml). For some experiments cells were incubated in starvation medium EBSS (Earle's balanced salt solution). Stably transfected CHO cells overexpressing pEGFP-LC3 were used. For some experiments CHO cells were transiently cotransfected with pRFP-LC3 and pGFP-Rap2B wt or pGFP-Rap2B ΔAAX; or with pGFP-LC3 and pCMV myc-Epac wt or myc-ΔEpac. Cells were cotransfected using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. Stably transfected CHO cells overexpressing pEGFP were used as control.

Treatment with the Toxin

Transfected CHO cells were incubated for 4 hours (h) with 10 µg/ml of α-hemolysin from S. aureus (Sigma Aldrich; Buenos Aires, Argentina). Cells were fixed and analyzed by confocal fluorescence microscopy.

Bacterial Strains and Growth Conditions

For infection experiments, S. aureus strains, wt (01016), the mutant deficient for α-hemolysin (Hla−) (01017), or the Hla(−) mutant complemented with an α-hemolysin plasmid (01018) were grown overnight at 37°C in 5 ml of LB broth with appropriate antibiotics. Bacteria were resuspended in infection medium containing 10% FCS and 20 mM HEPES, at an OD650 of 0.4 (∼4×108 CFU). Bacteria were diluted to achieve a multiplicity of infection (moi) of 10∶1 (bacteria∶cell) in the infection medium.

Fluorescence Microscopy

Transfected CHO cells were analyzed by fluorescence microscopy using an Olympus Confocal FV1000 (Japan) and processed with the program FV10-ASW 1.7. In some experiments, to visualize the pathogen, bacterial DNA was labeled with 45 nM TOPRO in Mowiol.

PKA and EPAC Activation

CHO GFP-LC3 cells were preincubated 30 min with 1 mM N6,2′-O-DIBUTYRYLADENOSINE 3′:5′-CYCLIC (dbcAMP; Sigma; Buenos Aires, Argentina) or 10 µM 8-pCPT-2′-O-Me-cAMP-AM (8-pCPT; BioLog; Bremen, Germany), and then they were treated with 10 µg/ml of α-hemolysin for 4 h or incubated in starvation medium for 2 h in the presence of the drugs. Cells were fixed and analyzed by confocal microscopy.

SDS-PAGE and Western Blot

CHO and HeLa cells were incubated under different conditions and lysed with sample buffer. Protein samples of a total cell lysate were run on a 10% polyacrylamide gel and transferred to Hybond-ECL (Amersham) nitrocellulose membranes. The membranes were blocked for 1 h in Blotto (5% non-fat milk, 0.1% Tween 20, and PBS), washed twice with PBS and incubated with a primary antibody anti-LC3 and a peroxidase-conjugated secondary antibody (Jackson Immuno Research, 211-032-171). Anti-tubulin (Jackson Immuno Research) was used as a loading control. The corresponding bands were detected using an enhanced chemiluminescence detection kit from Healthcare (Amersham, RPN2109) and the band was detected using Fujifilm LAS-4000.

PKA Inhibition

CHO GFP-LC3 cells were preincubated 30 min with 10 µM H89 in the presence or absence of 1 mM db cAMP, and then they were treated with 10 µg/ml of α-hemolysin for 4 h or incubated in starvation medium for 2 h in the presence of the inhibitor. Cells were fixed and analyzed by confocal microscopy.

Calpains Inhibition

CHO GFP-LC3 cells were preincubated 30 min with 10 µM calpeptin, in the presence or the absence of 1 mM dbcAMP. Subsequently, they were treated with 10 µg/ml of α-hemolysin for 4 h or incubated in starvation medium for 2 h. Cells were fixed and analyzed by confocal microscopy.

CFU Determination

CHO cells were infected for 3 h with the wt strain of S. aureus, the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid. Infected cells were washed with PBS and lysed in water at 4°C. Lysates were diluted with PBS, plated on LB agar and incubated for 12 h at 37°C. Colonies were counted on the plate with dilutions yielding 50–100 visible colonies as previously determined [21].

Rap2b-GTP Precipitation Assays

HeLa cells were incubated for 4 h in the presence or absence of 10 µg/ml Hla, or they were infected for 4 h with S. aureus wt strain or Hla (−) strain. Afterwards, cells were lysed in a GST pull-down buffer (200 mM NaCl, 2.5 mM MgCl2, 1% [v/v] Triton X-100, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, a protease inhibitor mixture [Pepstatin, Leupeptin and Trypsin inhibitor], and 50 mM Tris-HCl, pH 7.4) by sonication on ice (two times for 30 s) and used immediately. Glutathione-sepharose beads were washed twice with the GST pull-down buffer and incubated with bacterial lysates containing GST-Ral-GDS-RBD for 1 h at 4°C under constant rocking. Beads were washed twice with PBS and once with GST pull-down buffer and used immediately. Twenty µl of glutathione-sepharose containing 10 µg of the appropriate fusion protein was added to cell lysates in a total volume of 0.6 ml and incubated by rotation at 4°C for 1 h. The resin was recovered by centrifugation at 4°C (5 min at 10,000 rpm) and washed three times with ice-cold GST pull-down buffer [25]. The resin-bound fractions were resolved by SDS-PAGE, and cellular GTP-Rap2b levels were analyzed by immunoblotting as described earlier, using a primary antibody anti-Rap2b and a peroxidase-conjugated secondary antibody (Jackson Immuno Research).

Intracellular cAMP Measurement

CHO cells were incubated 4 h with 10 µg/ml of α-hemolysin or infected 4 h with the wt strain of S. aureus (01016) or the mutant deficient for Hla (01017). After incubations, cells were placed on ice, washed with PBS, and 0.7 ml cold 100% ethanol was added to each well. Cells were scraped and transferred to tubes (Eppendorf), sonicated twice for 2 min, and heated for 5 min at 95 C° to destroy endogenous proteins. Afterwards, the samples were centrifuged 5 min at 10,000 rpm. Supernatants were dried and kept at −20 C°. Samples were diluted in 200 µl of 50 mM sodium acetate buffer (pH 6.0). Unknown samples and standards were acetylated and assayed by RIA using the method described by Del Punta et al. [43]. The interassay and intraassay variations of coefficients were lower than 10%. Model showing the two cAMP-dependent pathways involved in the control of autophagy and the effect of different molecules on the autophagic response induced by Hla and by . (A) Different stimuli, like bacterial infections, may modulate the levels of intracellular cAMP, either increasing or decreasing the intracellular levels of this second messenger. When the levels of cAMP are augmented, autophagy can be inhibited via two different pathways: (Left) cAMP activates PKA, which is able to phosphorylate LC3-I, avoiding its conversion to LC3-II and preventing autophagy activation. (Right) On the other hand, cAMP can activate EPAC, which through Rap2b and PLCε activation induces an IP3 increase. In turn, this IP3 increase leads to calcium release from the endoplasmic reticulum, which activates the cysteine-protease calpains. These calpains are able to cleave Atg5, inhibiting the autophagic pathway. (B) Left: Inactivation of PKA with H89 does not prevent the inhibitory effect of cAMP on the Hla or S. aureus–induced autophagy, suggesting that this effect occurs via a PKA-independent pathway. Right: EPAC or Rap2b overexpression is sufficient to inhibit the autophagy induced by Hla or S. aureus, indicating that these proteins participate in the regulation of the autophagic response induced by this pathogen. Furthermore, inhibition of calpains with calpeptin allows autophagy activation induced by Hla even in the presence of cAMP, suggesting that inactivation of calpains is necessary for this autophagic response. (TIF) Click here for additional data file. Endogenous LC3 recruitment and Atg12-Atg5 complex formation are inhibited by cAMP treatment. (A) CHO cells were preincubated with 1 mM dybutiryl cAMP (+dbcAMP) for 30 min, and then they were treated for 4 h with 10 µg/ml of α-hemolysin (Hla), with 50 ng/µl of rapamycin (Rapa) in full nutrient media or subjected to starvation conditions (Stv) in the continuous presence of dbcAMP. Cells without any treatment were used as control (−dbcAMP). Endogenous LC3 was detected using a rabbit anti-LC3 and cells were visualized by confocal microscopy. These data are representative of three independent experiments. (B) CHO cells were incubated with complete medium in the absence (−dbcAMP) or presence of dbcAMP (+dbcAMP) and treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv). Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-Atg12 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of two independent experiments. The band intensities of two independent experiments were quantificated with the Adobe Photoshop program (lower panel). * p<0.05 (paired Student's t-test). (TIF) Click here for additional data file. Autophagic response upon Hla treatment in cells overexpressing the vectors RFP or GFP. (A) CHO cells were cotransfected with GFP-LC3 and RFP-Vector. Twenty-four hours after transfection, they were incubated for 2 h in starvation medium (Stv) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions (n = 50 cells/condition). These data are representative of two independent experiments. (C) CHO cells were cotransfected with RFP-LC3 and GFP-Vector. Twenty-four hours after transfection, they were incubated for 2 h in starvation medium (Stv), with 50 ng/µl of rapamycin (Rapa) in full nutrient media, or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of three independent experiments. (D) CHO cells were transfected with GFP-Vector and incubated for 4 h with complete medium without (Ctr) or with 10 µg/ml of α-hemolysin (Hla), with 50 ng/µl of rapamycin (Rapa) or subjected to starvation conditions (Stv) for 2 h. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. The band intensities were quantificated with the Adobe Photoshop program (lower panel). These data are representative of two independent experiments. (TIF) Click here for additional data file. infection after overexpression of the RFP-Vector. (A) CHO cells were cotransfected with GFP-LC3 and RFP-Vector. Twenty-four hours after transfection, they were infected for 4 h with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−)+pHla). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods and immediately visualized by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions (n = 50 cells/condition). These data are representative of two independent experiments. (TIF) Click here for additional data file. Endogenous EPAC and Rap2b are recruited to the –containing phagosomes. CHO cells were infected for 4 h with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−)+pHla). Endogenous EPAC (upper panels) and Rap2b (lower panels) were detected using a rabbit anti-EPAC and a rabbit anti-Rap2b, respectively. The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods and the samples were visualized by confocal microscopy. Quantifications of the percentage of bacteria decorated with endogenous EPAC or Rap2b upon the infection are shown in right panels. These data are representative of two independent experiments. (TIF) Click here for additional data file. Endogenous EPAC and Rap2b do not colocalize with LC3. CHO GFP-LC3 cells were infected for 4 h with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−)+pHla). Endogenous EPAC (upper panels) or Rap2b (lower panels) were detected using a rabbit anti-EPAC and a rabbit anti-Rap2b, respectively. The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods and the samples were visualized by confocal microscopy. These data are representative of two independent experiments. (TIF) Click here for additional data file.
  43 in total

1.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Authors:  Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

2.  A unified nomenclature for yeast autophagy-related genes.

Authors:  Daniel J Klionsky; James M Cregg; William A Dunn; Scott D Emr; Yasuyoshi Sakai; Ignacio V Sandoval; Andrei Sibirny; Suresh Subramani; Michael Thumm; Marten Veenhuis; Yoshinori Ohsumi
Journal:  Dev Cell       Date:  2003-10       Impact factor: 12.270

Review 3.  Development by self-digestion: molecular mechanisms and biological functions of autophagy.

Authors:  Beth Levine; Daniel J Klionsky
Journal:  Dev Cell       Date:  2004-04       Impact factor: 12.270

4.  The Ras/cAMP-dependent protein kinase signaling pathway regulates an early step of the autophagy process in Saccharomyces cerevisiae.

Authors:  Yelena V Budovskaya; Joseph S Stephan; Fulvio Reggiori; Daniel J Klionsky; Paul K Herman
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

5.  Inhibition of intracellular cAMP-dependent protein kinase using mutant genes of the regulatory type I subunit.

Authors:  C H Clegg; L A Correll; G G Cadd; G S McKnight
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

6.  Primary sequence of the alpha-toxin gene from Staphylococcus aureus wood 46.

Authors:  G S Gray; M Kehoe
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

Review 7.  Apoptosis and autophagy: decoding calcium signals that mediate life or death.

Authors:  Michael W Harr; Clark W Distelhorst
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-08       Impact factor: 10.005

Review 8.  The calpain system.

Authors:  Darrell E Goll; ValeryY F Thompson; Hongqi Li; Wei Wei; Jinyang Cong
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

9.  Activation of JNK by Epac is independent of its activity as a Rap guanine nucleotide exchanger.

Authors:  Daniel Hochbaum; Tamara Tanos; Fernando Ribeiro-Neto; Daniel Altschuler; Omar A Coso
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

Review 10.  cAMP effector mechanisms. Novel twists for an 'old' signaling system.

Authors:  Reidun Kopperud; Camilla Krakstad; Frode Selheim; Stein Ove Døskeland
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

View more
  30 in total

1.  Oleate disrupts cAMP signaling, contributing to potent stimulation of pancreatic β-cell autophagy.

Authors:  Kwan Yi Chu; Liam O'Reilly; Natalie Mellet; Peter J Meikle; Clarissa Bartley; Trevor J Biden
Journal:  J Biol Chem       Date:  2018-12-05       Impact factor: 5.157

2.  Autophagy mediates tolerance to Staphylococcus aureus alpha-toxin.

Authors:  Katie Maurer; Tamara Reyes-Robles; Francis Alonzo; Joan Durbin; Victor J Torres; Ken Cadwell
Journal:  Cell Host Microbe       Date:  2015-03-26       Impact factor: 21.023

Review 3.  Watch What You (Self-) Eat: Autophagic Mechanisms that Modulate Metabolism.

Authors:  Vikramjit Lahiri; Wayne D Hawkins; Daniel J Klionsky
Journal:  Cell Metab       Date:  2019-04-02       Impact factor: 27.287

4.  Junín Virus Promotes Autophagy To Facilitate the Virus Life Cycle.

Authors:  Julieta S Roldán; Nélida A Candurra; María I Colombo; Laura R Delgui
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

Review 5.  Rap2B GTPase: structure, functions, and regulation.

Authors:  Zhesi Zhu; Jiehui Di; Zheng Lu; Keyu Gao; Junnian Zheng
Journal:  Tumour Biol       Date:  2016-03-24

Review 6.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

7.  Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.

Authors:  Eun-Jin Choi; Yuping Ren; Yu Chen; Shengxuan Liu; Wenzhe Wu; Junping Ren; Pingyuan Wang; Roberto P Garofalo; Jia Zhou; Xiaoyong Bao
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

8.  Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Authors:  Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong
Journal:  Autophagy       Date:  2021-02-08       Impact factor: 13.391

9.  Suppression of starvation-induced autophagy by recombinant toxic shock syndrome toxin-1 in epithelial cells.

Authors:  Krisana Asano; Yoshiya Asano; Hisaya K Ono; Akio Nakane
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 10.  Autophagic clearance of bacterial pathogens: molecular recognition of intracellular microorganisms.

Authors:  Maria Eugenia Mansilla Pareja; Maria I Colombo
Journal:  Front Cell Infect Microbiol       Date:  2013-09-30       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.